According to a report presented at last year’s World Economic Forum on ASEAN, a healthcare spending cris...Read more
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, first established its presen...Read more
GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therap...Read more
Doctors may one day be able to diagnose Alzheimer’s disease (AD), the most common cause of severe dement...Read more
Cochlear Limited, the global leader in implantable hearing solutions announced the U.S. Food and Drug Administ...Read more
Agilent Technologies Inc. has announced the opening of a production facility in Colorado that more than double...Read more
ASIA-PACIFIC: MODEST RISE IN HEALTHCARE DEALS
Healthcare private equity tends to be less vulnerable to downturns than other sectors, so it expects demand for assets in Asia-Pacific to increase over the coming years. Buyout funds will invest more in growth-stage assets such as Chinese pharma. And as companies explore ways to increase access to healthcare, emerging trends, such as digital healthcare solutions, should gain steam in China, India and other countries. Investors will continue to seek deals in the provider and medtech sectors, and explore creative ways to deploy capital, such as public-toprivate takeovers. Baker McKenzie Global Transactions Forecast predicts a modest rise of 7 per cent in deals to $331 billion in 2019, as a number of cross-border and domestic megadeals are set to close.